Back to companies

BOSTON SCIENTIFIC CORP

BSXUSNYSEPharmaceuticals & Healthcare

BOSTON SCIENTIFIC CORP

Revenue
$20.1bn
YoY +19.9%
Operating income
$3.6bn
FY2025
Employees
—
Founded
—

Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API